Madrid, Spain

Javier Cillero

This inventor holds 1 USPTO granted patent. Top assignee: Alter, S.a.. Active years: 1988.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Javier Cillero: Innovator in Antithrombotic Drug Development

Introduction

Javier Cillero is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antithrombotic drugs. His innovative work has led to the creation of new compounds that have the potential to improve patient outcomes in the treatment of thrombotic conditions.

Latest Patents

Cillero holds a patent for "1,4-Dihydropiridines and their use as antithrombotic drugs." This invention refers to new 1,4-dihydropyridines, their obtention processes, and their application as antithrombotic agents. The new compounds have a general formula wherein R represents hydrogen or a saturated or unsaturated alkyl group, with a linear or branched chain of 1 to 8 carbon atoms. This patent highlights his commitment to advancing medical science and improving therapeutic options.

Career Highlights

Throughout his career, Javier Cillero has demonstrated a strong dedication to research and innovation. His work has not only contributed to the scientific community but has also paved the way for new treatments that can benefit patients suffering from thrombotic disorders. His expertise in the field has established him as a respected figure among his peers.

Collaborations

Cillero has collaborated with notable colleagues, including Carlos Sunkel and Miguel Fau De Casa-Juana. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of innovative solutions in the pharmaceutical industry.

Conclusion

Javier Cillero's contributions to the field of antithrombotic drug development exemplify the impact of innovation in medicine. His patent for 1,4-dihydropiridines showcases his dedication to improving healthcare through scientific advancement.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…